The modulation of ICs and their ligands by NRF2 and related transcription factors highlights a mechanistic link between oxidative stress and immune regulation, which may be relevant in cancer, chronic inflammation, and metabolic disease. The gene discussed is NFE2L2; the disease is cancer.